For instance, epigenetic events (mostly DNA methylation-driven) can cause RIPK3 protein suppression in several human cancer cell lines, including breast cancer [201], colorectal cancer (CRC) [202] and acute myeloid leukemia (AML) [203] (in nearly 2/3rd of >60 human cell lines tested). This evidence concerns the gene RIPK3 and cancer.